Skip to main content
Log in

Working memory training for adult glioma patients: a proof-of-concept study

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Background

CogMed Working Memory Training (CWMT) is a computer-based program shown to improve working memory (WM) among those with cognitive impairments. No study to date has investigated its feasibility, acceptability, and satisfaction in adult patients with glioma, despite the well-documented incidence of WM impairment in this population.

Methods

Twenty patients with glioma and objective and/or perceived WM deficits enrolled in the study: 52% high-grade, 60% female, Mage = 47 (range = 21–72 years). Adverse events were monitored to determine safety. Feasibility and acceptability were assessed based on established metrics. Satisfaction was explored by exit-interviews. Neurocognitive tests and psychological symptoms were analyzed at baseline and post-CWMT to estimate effect sizes.

Results

Of 20 enrolled patients, 16 completed the intervention (80% retention rate). Reasons for withdrawal included time burden (n = 2); tumor-related fatigue (n = 1) or loss to follow-up (n = 1). No adverse events were determined to be study-related. Adherence was 69% with reasons for nonadherence similar to those for study withdrawal. The perceived degree of benefit was only moderate. Baseline to post-CWMT assessments showed medium to large effects on neurocognitive tasks. Psychological symptoms remained stable throughout the study period.

Conclusions

CWMT was found to be safe and acceptable in adult patients with glioma. Enrollment, retention rates, and treatment adherence were all adequate and comparable to studies recruiting similar populations. Only moderate perceived benefit was reported despite demonstrated improvements in objectively-assessed WM. This may indicate that the time commitment and intervention intensity (5 weeks of 50-min training sessions on 5 days/week) outweighed the perceived benefits of the program. (Trial Registration Number: NCT03323450 registered on 10/27/2017).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324–333. https://doi.org/10.1097/00006123-200008000-00011 (discussion 333–334)

    Article  CAS  PubMed  Google Scholar 

  2. Zucchella C, Bartolo M, Di Lorenzo C et al (2013) Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey. J Neurooncol 112:455–460

    Article  CAS  PubMed  Google Scholar 

  3. Meyers CA, Hess KR, Yung WK, Levin VA (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18:646–650. https://doi.org/10.1200/jco.2000.18.3.646

    Article  CAS  PubMed  Google Scholar 

  4. Noll KR, Ziu M, Weinberg JS, Wefel JS (2016) Neurocognitive functioning in patients with glioma of the left and right temporal lobes. J Neurooncol 128:323–331. https://doi.org/10.1007/s11060-016-2114-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. McAleer MF, Brown PD (2015) Neurocognitive function following therapy for low-grade gliomas. Semin Radiat Oncol 25:210–218. https://doi.org/10.1016/j.semradonc.2015.02.005

    Article  PubMed  Google Scholar 

  6. Pendergrass C, Targum S, Harrison J (2018) Cognitive impairment associated with Cancer: A brief review. Innov Clin Neurosci 15:36–44

    PubMed  PubMed Central  Google Scholar 

  7. Teixidor P, Gatignol P, Leroy M et al (2007) Assessment of verbal working memory before and after surgery for low-grade glioma. J Neurooncol 81:305–313. https://doi.org/10.1007/s11060-006-9233-y

    Article  PubMed  Google Scholar 

  8. Gehrke AK, Baisley MC, Sonck ALB et al (2013) Neurocognitive deficits following primary brain tumor treatment: systematic review of a decade of comparative studies. J Neurooncol 115:135–142

    Article  PubMed  Google Scholar 

  9. Cowan N (2014) Working memory underpins cognitive development, learning, and education. Educ Psychol Rev 26:197–223

    Article  PubMed  Google Scholar 

  10. Groves NB, Kofler MJ, Wells EL et al (2020) An examination of relations among working memory, ADHD symptoms, and emotion regulation. J Abnorm Child Psychol 48:525–537. https://doi.org/10.1007/s10802-019-00612-8

    Article  PubMed  PubMed Central  Google Scholar 

  11. Mlinac ME, Feng MC (2016) Assessment of activities of daily living, self-care, and independence. Arch Clin Neuropsychol 31:506–516. https://doi.org/10.1093/arclin/acw049

    Article  PubMed  Google Scholar 

  12. Schagen SB, Klein M, Reijneveld JC et al (2014) Monitoring and optimising cognitive function in cancer patients: present knowledge and future directions. Eur J Cancer Suppl 12:29–40. https://doi.org/10.1016/j.ejcsup.2014.03.003

    Article  CAS  Google Scholar 

  13. Loughan AR, Braun SE, Lanoye A (2019) Executive dysfunction in neuro-oncology: behavior rating inventory of executive function in adult primary brain tumor patients. Appl Neuropsychol Adult. https://doi.org/10.1080/23279095.2018.1553175

    Article  PubMed  Google Scholar 

  14. Loughan AR, Allen DH, Baumstarck K et al (2018) Quality of life in neuro-oncology. Handb Brain Tumor Chemother Mol Ther Immunother. https://doi.org/10.1016/B978-0-12-812100-9.00061-9

    Article  Google Scholar 

  15. Klingberg T, Fernell E, Olesen PJ et al (2005) Computerized training of working memory in children with ADHD - a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 44:177–186. https://doi.org/10.1097/00004583-200502000-00010

    Article  PubMed  Google Scholar 

  16. Björkdahl A, Åkerlund E, Svensson S, Esbjörnsson E (2013) A randomized study of computerized working memory training and effects on functioning in everyday life for patients with brain injury. Brain Inj 27:1658–1665. https://doi.org/10.3109/02699052.2013.830196

    Article  PubMed  Google Scholar 

  17. Hardy KK, Willard VW, Allen TM, Bonner MJ (2013) Working memory training in survivors of pediatric cancer: a randomized pilot study. Psychooncology 22:1856–1865. https://doi.org/10.1002/pon.3222

    Article  PubMed  Google Scholar 

  18. Raskin S (2011) Neuroplasticity and rehabilitation. Guilford Publications

  19. Aksayli ND, Sala G, Gobet F (2019) The cognitive and academic benefits of Cogmed: a meta-analysis. Educ Res Rev 27:229–243

    Article  Google Scholar 

  20. Sacks-Zimmerman A, Duggal D, Liberta T (2015) Cognitive remediation therapy for braintumor survivors with cognitive deficits. Cureus. https://doi.org/10.7759/cureus.350

    Article  PubMed  PubMed Central  Google Scholar 

  21. Liberta TA, Kagiwada M, Ho K et al (2020) An investigation of COGMED working memory training for neurological surgery patients. Interdiscip Neurosurg Adv Tech Case Manag. https://doi.org/10.1016/j.inat.2020.100786

    Article  Google Scholar 

  22. Poleon S, Szaflarski JP (2017) Targeted review photosensitivity in generalized epilepsies ☆. https://doi.org/10.1016/j.yebeh.2016.10.040

  23. Vecht CJ, Kerkhof M, Duran-Pena A (2014) Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist 19:751–759. https://doi.org/10.1634/theoncologist.2014-0060

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Boele FW, Zant M, Heine ECE et al (2014) The association between cognitive functioning and health-related quality of life in low-grade glioma patients. Neuro-oncology. https://doi.org/10.1093/nop/npu007

    Article  PubMed Central  Google Scholar 

  25. Habets EJJ, Kloet A, Walchenbach R et al (2014) Tumour and surgery effects on cognitive functioning in high-grade glioma patients. Acta Neurochir (Wien) 156:1451–1459. https://doi.org/10.1007/s00701-014-2115-8

    Article  Google Scholar 

  26. Czajkowski SM, Powell LH, Adler N et al (2015) From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases. Heal Psychol 34:971–982. https://doi.org/10.1037/hea0000161

    Article  Google Scholar 

  27. Pearson (2009) Advanced Clinical Solutions for WAIS-IV and WMS-IV

  28. Randolph C (2009) RBANS Update Repeatable Battery for the Assessment of Neuropsychological Status: Manual. Pearson

  29. Roth RM, Isquith PM, Giola GA (2005) BRIEF—A: behavior rating inventory of executive function— adult version. Psychological Assessment Resources, Lutz, FL

  30. Richard NM, Bernstein LJ, Mason WP et al (2019) Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. J Neurooncol 142:565–575. https://doi.org/10.1007/s11060-019-03130-1

    Article  PubMed  Google Scholar 

  31. Peterson AL, Roache JD, Raj J, Young-McCaughan S (2013) The need for expanded monitoring of adverse events in behavioral health clinical trials. Contemp Clin Trials. https://doi.org/10.1016/j.cct.2012.10.009

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lancaster GA, Dodd S, Williamson PR (2004) Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 10:307–312. https://doi.org/10.1111/j.2002.384.doc.x

    Article  PubMed  Google Scholar 

  33. Leon AC, Davis LL, Kraemer HC (2011) The role and interpretation of pilot studies in clinical research. J Psychiatr Res 45:626–629. https://doi.org/10.1016/j.jpsychires.2010.10.008

    Article  PubMed  Google Scholar 

  34. Vranceanu A-M, Jacobs C, Lin A et al (2019) Results of a feasibility randomized controlled trial (RCT) of the Toolkit for Optimal Recovery (TOR): a live video program to prevent chronic pain in at-risk adults with orthopedic injuries. Pilot feasibility Stud 5:30. https://doi.org/10.1186/s40814-019-0416-7

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hassler MR, Elandt K, Preusser M et al (2010) Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol 97:109–115. https://doi.org/10.1007/s11060-009-0006-2

    Article  PubMed  Google Scholar 

  36. Gehring K, Sitskoorn MM, Gundy CM et al (2009) Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol 27:3712–3722. https://doi.org/10.1200/JCO.2008.20.5765

    Article  PubMed  Google Scholar 

  37. Lonkhuizen PJC, Klaver KM, Wefel JS et al (2019) Interventions for cognitive problems in adults with brain cancer: a narrative review. Eur J Cancer Care (Engl). https://doi.org/10.1111/ecc.13088

    Article  Google Scholar 

  38. Agar M, Koh ES, Gibbs E et al (2016) Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity. Support Care Cancer. https://doi.org/10.1007/s00520-015-2897-0

    Article  PubMed  Google Scholar 

  39. Cantisano N, Menei P, Roualdes V et al (2020) Patient-reported functional executive challenges and caregiver confirmation in adult brain tumor survivors. J Cancer Surviv. https://doi.org/10.1007/s11764-020-00961-0

    Article  PubMed  Google Scholar 

  40. van der Linden SD, Gehring K, De Baene W et al (2020) Assessment of executive functioning in patients with meningioma and low-grade glioma: a comparison of self-report, proxy-report, and test performance. J Int Neuropsychol Soc. https://doi.org/10.1017/S1355617719001164

    Article  PubMed  Google Scholar 

  41. Duff K, Schoenberg MR, Mold JW et al (2007) Normative and retest data on the RBANS cortical/subcortical index in older adults. J Clin Exp Neuropsychol. https://doi.org/10.1080/13803390601147629

    Article  PubMed  Google Scholar 

  42. Krogh Rasmussen B, Hansen S, Laursen RJ et al (2017) Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry. J Neurooncol 135:571–579. https://doi.org/10.1007/s11060-017-2607-5

    Article  Google Scholar 

  43. Sattler J, Ryan J (2009) Assessment with the WAIS-IV

  44. Drozdick L, Holdnack J, Hilsabeck R (2011) Essentials of WMS-IV assessment

  45. Heaton RK, Miller S, Taylor M, Grant I (2004) Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults scoring programs

  46. Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9. J Gen Intern Med 16:605–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x

    Article  Google Scholar 

  47. Spitzer RL, Kroenke K, Williams JBW, Löwe B (2006) A brief measure for assessing generalized anxiety disorder. Arch Intern Med 166:1092. https://doi.org/10.1001/archinte.166.10.1092

    Article  PubMed  Google Scholar 

  48. Beck AT, Steer RA, Brown GK (1996) BDI-II, Beck depression inventory : manual, Second edition

  49. Wilson KA, de Beurs E, Palmer CA, Chambless DL (1999) Beck Anxiety Inventory. In: Maruish ME (ed) The use of psychological testing for treatment planning and outcomes assessment. Lawrence Erlbaum Associates Publishers, Mahwah, NJ, US

    Google Scholar 

  50. Beck AT, Steer RA, Brown GK (1996) Manual for the beck depression inventory-second edition. The Psychological Corporation, San Antonio, TX

    Google Scholar 

  51. Beck AT, Steer RA (1993) BAI, Beck anxiety inventory: manual, 1993rd edn. Psychological Corporation, San Antonio

    Google Scholar 

Download references

Acknowledgements

Thank you to all of our patients. We would also like to thank our research assistants Kelcie Willis and Julia Brechbiel for their contributions to this project.

Funding

VCU School of Medicine Deans Academic Enhancement Award. The project described was also supported by CTSA award No. KL2TR002648 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: SB, PhD, FA, MS, AL, PhD, AL, PhD; Methodology: SB, PhD, AL, PhD; Formal analysis and investigation: SB, PhD, FA, MS, AL, PhD, SF-Z, PhD; Writing – original draft preparation: SB, PhD, FA, MS; Writing – review and editing: SB, PhD, FA, MS, AL, PhD, SF-Z, PhD, MM, MD, AL, PhD; Funding acquisition: AL, PhD, MM, MD; Resources: AL, PhD, MM, PhD; Supervision: AL, PhD, SB, PhD, MM, PhD.

Corresponding author

Correspondence to Sarah Ellen Braun.

Ethics declarations

Conflict of interest

The authors have no conflict of interests to disclose.

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

Ethical approval

Approval was obtained from the ethics committee of Virginia Commonwealth University and Massey Cancer Center. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Braun, S.E., Aslanzadeh, F.J., Lanoye, A. et al. Working memory training for adult glioma patients: a proof-of-concept study. J Neurooncol 155, 25–34 (2021). https://doi.org/10.1007/s11060-021-03839-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-021-03839-y

Keywords

Navigation